Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy
SCFFBXW7 E3 ubiquitin ligase complex is a crucial enzyme of the ubiquitin proteasome system that participates in variant activities of cell process, and its component FBXW7 (F-box and WD repeat domain–containing 7) is responsible for recognizing and binding to substrates. The expression of FBXW7 is...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-06-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.925041/full |
| _version_ | 1811237401934168064 |
|---|---|
| author | Liangliang Xing Leidi Xu Yong Zhang Yinggang Che Min Wang Yongxiang Shao Dan Qiu Honglian Yu Feng Zhao Jian Zhang |
| author_facet | Liangliang Xing Leidi Xu Yong Zhang Yinggang Che Min Wang Yongxiang Shao Dan Qiu Honglian Yu Feng Zhao Jian Zhang |
| author_sort | Liangliang Xing |
| collection | DOAJ |
| description | SCFFBXW7 E3 ubiquitin ligase complex is a crucial enzyme of the ubiquitin proteasome system that participates in variant activities of cell process, and its component FBXW7 (F-box and WD repeat domain–containing 7) is responsible for recognizing and binding to substrates. The expression of FBXW7 is controlled by multiple pathways at different levels. FBXW7 facilitates the maturity and function maintenance of immune cells via functioning as a mediator of ubiquitination-dependent degradation of substrate proteins. FBXW7 deficiency or mutation results in the growth disturbance and dysfunction of immune cell, leads to the resistance against immunotherapy, and participates in multiple illnesses. It is likely that FBXW7 coordinating with its regulators and substrates could offer potential targets to improve the sensitivity and effects of immunotherapy. Here, we review the mechanisms of the regulation on FBXW7 and its tumor suppression role in immune filed among various diseases (mostly cancers) to explore novel immune targets and treatments. |
| first_indexed | 2024-04-12T12:23:46Z |
| format | Article |
| id | doaj.art-e7e145ab3ae14c59a44e1a89d27ca90f |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-04-12T12:23:46Z |
| publishDate | 2022-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-e7e145ab3ae14c59a44e1a89d27ca90f2022-12-22T03:33:13ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-06-011210.3389/fonc.2022.925041925041Recent Insight on Regulations of FBXW7 and Its Role in ImmunotherapyLiangliang Xing0Leidi Xu1Yong Zhang2Yinggang Che3Min Wang4Yongxiang Shao5Dan Qiu6Honglian Yu7Feng Zhao8Jian Zhang9Department of Pulmonary Medicine, Xijing Hospital, Air Force Medical University, Xi’an, ChinaDepartment of Pulmonary Medicine, Xijing Hospital, Air Force Medical University, Xi’an, ChinaDepartment of Pulmonary Medicine, Xijing Hospital, Air Force Medical University, Xi’an, ChinaDepartment of Pulmonary Medicine, Xijing Hospital, Air Force Medical University, Xi’an, ChinaDepartment of Pulmonary Medicine, Xijing Hospital, Air Force Medical University, Xi’an, ChinaDepartment of Anus and Intestine Surgery, The 942th Hospital of Joint Logistics Support Force, Yinchuan, ChinaDepartment of Pulmonary Medicine, Xijing Hospital, Air Force Medical University, Xi’an, ChinaDepartment of Hemato-Oncology, The 942th Hospital of Joint Logistics Support Force, Yinchuan, ChinaDepartment of Pulmonary Medicine, Xijing Hospital, Air Force Medical University, Xi’an, ChinaDepartment of Pulmonary Medicine, Xijing Hospital, Air Force Medical University, Xi’an, ChinaSCFFBXW7 E3 ubiquitin ligase complex is a crucial enzyme of the ubiquitin proteasome system that participates in variant activities of cell process, and its component FBXW7 (F-box and WD repeat domain–containing 7) is responsible for recognizing and binding to substrates. The expression of FBXW7 is controlled by multiple pathways at different levels. FBXW7 facilitates the maturity and function maintenance of immune cells via functioning as a mediator of ubiquitination-dependent degradation of substrate proteins. FBXW7 deficiency or mutation results in the growth disturbance and dysfunction of immune cell, leads to the resistance against immunotherapy, and participates in multiple illnesses. It is likely that FBXW7 coordinating with its regulators and substrates could offer potential targets to improve the sensitivity and effects of immunotherapy. Here, we review the mechanisms of the regulation on FBXW7 and its tumor suppression role in immune filed among various diseases (mostly cancers) to explore novel immune targets and treatments.https://www.frontiersin.org/articles/10.3389/fonc.2022.925041/fullFBXW7ubiquitinationepigenetic regulationimmunityimmunotherapy |
| spellingShingle | Liangliang Xing Leidi Xu Yong Zhang Yinggang Che Min Wang Yongxiang Shao Dan Qiu Honglian Yu Feng Zhao Jian Zhang Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy Frontiers in Oncology FBXW7 ubiquitination epigenetic regulation immunity immunotherapy |
| title | Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy |
| title_full | Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy |
| title_fullStr | Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy |
| title_full_unstemmed | Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy |
| title_short | Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy |
| title_sort | recent insight on regulations of fbxw7 and its role in immunotherapy |
| topic | FBXW7 ubiquitination epigenetic regulation immunity immunotherapy |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2022.925041/full |
| work_keys_str_mv | AT liangliangxing recentinsightonregulationsoffbxw7anditsroleinimmunotherapy AT leidixu recentinsightonregulationsoffbxw7anditsroleinimmunotherapy AT yongzhang recentinsightonregulationsoffbxw7anditsroleinimmunotherapy AT yinggangche recentinsightonregulationsoffbxw7anditsroleinimmunotherapy AT minwang recentinsightonregulationsoffbxw7anditsroleinimmunotherapy AT yongxiangshao recentinsightonregulationsoffbxw7anditsroleinimmunotherapy AT danqiu recentinsightonregulationsoffbxw7anditsroleinimmunotherapy AT honglianyu recentinsightonregulationsoffbxw7anditsroleinimmunotherapy AT fengzhao recentinsightonregulationsoffbxw7anditsroleinimmunotherapy AT jianzhang recentinsightonregulationsoffbxw7anditsroleinimmunotherapy |